Superparamagnetic Iron Oxide

DRUG3 trials

Sponsors

Vastra Gotaland Region

Conditions

Breast CancerMelanoma (Skin Cancer)Sentinel Lymph Node

Phase 1

Sentinel Node Localization and Staging with Low Dose Superparamagnetic Iron Oxide

CompletedNCT05359783

Vastra Gotaland RegionBreast Cancer, Sentinel Lymph Node

Start: 2021-11-01End: 2024-04-30Updated: 2025-03-28

Phase 2

Sentinel Lymph Node Localisation With an Ultra-low Dose of Magtrace in Breast Cancer Patients

RecruitingNCT06169072

Vastra Gotaland RegionBreast Cancer, Sentinel Lymph Node

Start: 2023-01-01End: 2027-07-01Target: 220Updated: 2024-01-26

Phase 3

Superparamagnetic Iron Oxide for Sentinel Lymph Node Localization in Patients With Cutaneous Melanoma, a Randomized Phase III Multi-center Non- Inferiority Trial: MagMen-II

Not yet recruitingNCT07552597

Vastra Gotaland RegionMelanoma (Skin Cancer)

Start: 2026-05-04End: 2029-12-31Target: 254Updated: 2026-04-27